Replies to post #121352 on Bioelectronics Corp (BIEL)

[Moke31]

Nice reminder for everyone!!!!!!

[pearsby09]

Thanks Srinsocal, everyone should revist your post once in a while to realize the potential. I have added a few ancillary items to your list.

Baby Boomers growing exponentially into the pain market

Inquiries to company dramatically increasing

Opiate crisis shifting a need to other pain treatment modalities

New implemented Model with Pharmacy partners to engage Pharmacists with the patient..proactively educating and exposing them to ACTIPATCH as a pain treatment alternative.

We talk about the NHS reimbursement, but it is the data that speaks louder than the reimbursement "N=5000". As I said in a previous post, I hope they leverage the NHS approval and data starting YESTERDAY with all their partners..ANDA, PH, MUNDI, CARE, BOOTS etc...

[Simpsonly]

Great post srin, thanks.
I can think of no other company than BIEL, in any country, or trading on any exchange, other than the U.S. becoming great again under the current administration that has achieved as much or generated this much potential for profitability in the past year. Why BIEL is not trading at 5 to 7.5 cents is beyond rational thinking. The market should have already discounted for and adjusted in the NHS development. Someone on the Street I trust advised me late last week that something must be up for BIEL to be holding down at this level. He also felt my estimate is conservative.....call me curious....

[wagris]

Excellent reporting srinsocal, LUV IT...

[GetSeriousOK]

that's funny, only going back to 11/30/2017 "for those with a short memory...."

[JustGoDeep]

Actually Read the Post and this is Qualified

as the last 2 months of Biel News.

All that is the forerunner to what is going to Produce

a Revolution in the Treatment of Pain.

Freaky Amazing Device!!

Cake is in the Oven Baking!!

Smell That??

MONEY, THAT is the SMELL of MONEY!!

MoNsTeR !!

Read the linked post for GREAT INFORMATION!!

[art2426]

sr, I just read this (your) post and the only thing I can say is:

TRIPLE ZEROES, REALLY???????

[JustGoDeep]

---Latest Info in Post and Linked Post---

Biel: Current Market Cap $18 Million
FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting. Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute

Keep in mind People Biel

now has Purdue's Mundi Pharmaceuticals on board in 23 Countries,

Teva's ANDA, INC. selling in America, and Patterson Medical's Performance Health

also selling in America.

Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.

Patterson Medical's Performance Health has 120 Boots on the Ground and 40 online sales people

calling on all the physical therapy clinics in America, and most of the Long Term Facilities in America.

Using the NHS decision data of saving $582.00 per patient when they use Actipatch,

the Future for Biel has Never been brighter!!

https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf

NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.

https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html

Great Interview with their go to guy for sales and marketing.

https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/

Study NHS made their decision on.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf


-----------------------------

The-National-Health-System-has-given-its-approval-to-the ActiPatch, a wearable device that manages peripheral nerve activity to help users suffering from pain. The government-funded health service will now allow UK physicians to prescribe ActiPatch Musculoskeletal Pain Therapy and reimburse them for the digital health offering.

“This is a major win for pain sufferers in the UK, since they will now be able to obtain a prescription for ActiPatch, the cost of which will be covered by the government,” Ian Rawe, PhD, Director of Clinical Research for BioElectronics, the Maryland-based developer of the ActiPatch, said in a press release. “We commend this move by the NHS, as this will open up the doors for reimbursement in the US and other managed care markets.”

UK researchers estimated in 2016 that roughly 43 percent of the nation’s adult population, or about 29 million people, are affected by chronic pain (estimates have placed that figure at 100 million in the US). As in the US and other countries, treatment generally consists of a combination of physical therapy and medication – the likes of which have led to an increase in opioid dependence and abuse.

BioElectronics officials say NHS approval was linked to a study in which treatment with the mHealth wearable helped reducers reduce their trips to the doctor’s office by almost 60 percent and cut prescription drug costs by 35 percent, resulting in an overall reduction in healthcare costs of 45 percent.

------------------------

So much Great News will come out in

the next 6 months that I expect "at least" a 1000% increase.

But let's do some pricing to place a PE value on the Company.

$1,000,000 a quarter in Profit is $4,000,000 (Million) a year.

18 Billion shares outstanding and 20 Billion Authorized. I will use the 20 Billion figure.

$4,000,000 divided by 20 Billion = $.0002 X PE =

PE 30 = $.0060

PE 60 = $.012

PE 120 =$.024

High growth companies can sport a much higher PE.

Those numbers are for just a lousy $250,000 profit in a quarter.

How high will Profit be in Q2, Q3 and Q4.

So by the time this company is making profit of $5 million a quarter or $20 Million a year

and it will, the price per share will be at least PE 60 and at least $.06 per share.

Can it achieve that by Q2, Q3, or after Q4 earnings, I do believe so.

Could it do substantially more? Absolutely. Less, perhaps, but this is going to be huge.

Stock Rating: SUPER MONSTER

[JustGoDeep]

MARKET MAKERS WANT YOUR SHARES

BIEL WILL BE BRUTALIZE IN THE COMING DAYS AND WEEKS!

TOO MUCH MONEY TO BE MADE!!

HUNKER DOWN!!

[JustGoDeep]

HERE is the REALLY BIG News fo BIEL

NHS paying for Actipatches.

100,000 a day see a doctor for pain every day in the U.K.

Study says after paying for 10.8 Actipatches a year they save $534 dollars a year for each user.

Savings to NHS is between $5.6 and $9.8 Billion dollars a year.

That--IS--what the study says. How much do you think Biel gets for saving THAT much money?

This makes BIEL instantly Profitable, Period.

Here is the News.

https://finance.yahoo.com/news/bioelectronics-actipatch-drug-free-pain-120000840.html

Here is the Study.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf

Take it to the Bank. This is a really big deal folks.

Possibly profitable Q1 and surely Q2!!

See linked post for GREAT information from the President of Communications for the Biel Board.

ME; I have a PHD in Biel and am the self appointed Newbie Educator.

[JustGoDeep]

HERE is the REALLY BIG News fo BIEL

NHS paying for Actipatches.

100,000 a day see a doctor for pain every day in the U.K.

Study says after paying for 10.8 Actipatches a year they save $534 dollars a year for each user.

Savings to NHS is between $5.6 and $9.8 Billion dollars a year.

That--IS--what the study says. How much do you think Biel gets for saving THAT much money?

This makes BIEL instantly Profitable, Period.

Here is the News.

https://finance.yahoo.com/news/bioelectronics-actipatch-drug-free-pain-120000840.html

Here is the Study.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf

Take it to the Bank. This is a really big deal folks.

Possibly profitable Q1 and surely Q2!!

See linked post for GREAT information from the President of Communications for the Biel Board.

ME; I have a PHD in Biel and am the self appointed Newbie Educator.

[JustGoDeep]

Clue: Three Major Pharma Companies NOW

Now selling Actipatches for Biel.

Purdue's Mundipharma sells in 23 Countries

Two are selling in America.

Teva's ANDA, Inc.
Patterson Medical's Performance Health

Teva's ANDA has 60,000 customer base. Over 10,000 are pharmacies.

Performance Health calls on all the physical therapy clinics and Long Term Care Facilities.

NHS has approved reimbursement, it is the single largest single payer Healthcare System in the World.

100,000 see a doctor every day for chronic pain. Average user uses 10.8 Actipatches a year for pain.

Expected saving according to the study is $5.6 Billion to $9.8 Billions.

It is right here in black and white.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf

Do the freaking math on just 1%.

Clue: Nearly $30 Million Profit !!

Heck do the math on .5%!!

Now do the match on 5% 10% 20% 30% 50%.

LOCK YOUR SHARES UP AND DON"T LET THE TREE SHAKING GET YOU!

IT IS GOING TO GET REALLY NASTY HERE SOON!!

STOCK RATING: SUPER MONSTER

Quarter 2 will be exponential and profitable.

[JustGoDeep]

Clue: Three Major Pharma Companies NOW

Now selling Actipatches for Biel.

Purdue's Mundipharma sells in 23 Countries

Two are selling in America.

Teva's ANDA, Inc.
Patterson Medical's Performance Health

Teva's ANDA has 60,000 customer base. Over 10,000 are pharmacies.

Performance Health calls on all the physical therapy clinics and Long Term Care Facilities.

NHS has approved reimbursement, it is the single largest single payer Healthcare System in the World.

It is the Countries of the the U.K. or Great Britain and Northern Ireland.

100,000 see a doctor every day for chronic pain. Average user uses 10.8 Actipatches a year for pain.

Expected saving according to the study is $5.6 Billion to $9.8 Billions.

It is right here in black and white.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf

Do the freaking math on just 1%.

Clue: Nearly $30 Million Profit !!

Heck do the math on .5%!!

Now do the match on 5% 10% 20% 30% 50%.

LOCK YOUR SHARES UP AND DON"T LET THE TREE SHAKING GET YOU!

IT IS GOING TO GET REALLY NASTY HERE SOON!!

STOCK RATING: SUPER MONSTER

Quarter 2 will be exponential and profitable.

[JustGoDeep]

Clue: Three Major Pharma Companies NOW

Now selling Actipatches for Biel.

Two are selling in America.

One of which calls on all the physical therapy clinics.

NHS has approved reimbursement, it is the single largest single payer Healthcare System in the World.

[JustGoDeep]

BIEL THE MONSTER GETTING CLOSER +++++++++

Biel: Current Market Cap $18 Million

FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting.
Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute

Average user uses 10.8 Actipatches per year, per the U.K. Study.

Keep in mind People Biel

now has Purdue's Mundi Pharmaceuticals on board in 23 Countries,

Teva's ANDA, INC. selling in America, and Patterson Medical's Performance Health

also selling in America.

Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.

Performance Health has 120 Boots on the Ground and 40 online sales people calling on

all the physical therapy clinics in America, and most of the Long Term Facilities in America.

Using the NHS decision data of saving $582.00 per patient when they use Actipatch,

the Future for Biel has Never been brighter!!

https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf

NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.


https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html

Great Interview with their go to guy for sales and marketing.

https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/

Study NHS made their decision on. 10.8 Actipatches used a year per patient.



http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf


-----------------------------

The-National-Health-System-has-given-its-approval-to-the ActiPatch, a wearable device that manages peripheral nerve activity to help users suffering from pain. The government-funded health service will now allow UK physicians to prescribe ActiPatch Musculoskeletal Pain Therapy and reimburse them for the digital health offering.

“This is a major win for pain sufferers in the UK, since they will now be able to obtain a prescription for ActiPatch, the cost of which will be covered by the government,” Ian Rawe, PhD, Director of Clinical Research for BioElectronics, the Maryland-based developer of the ActiPatch, said in a press release. “We commend this move by the NHS, as this will open up the doors for reimbursement in the US and other managed care markets.”

UK researchers estimated in 2016 that roughly 43 percent of the nation’s adult population, or about 29 million people, are affected by chronic pain (estimates have placed that figure at 100 million in the US). As in the US and other countries, treatment generally consists of a combination of physical therapy and medication – the likes of which have led to an increase in opioid dependence and abuse.

BioElectronics officials say NHS approval was linked to a study in which treatment with the mHealth wearable helped reducers reduce their trips to the doctor’s office by almost 60 percent and cut prescription drug costs by 35 percent, resulting in an overall reduction in healthcare costs of 45 percent.

------------------------

So much Great News will come out in

the next 6 months that I expect "at least" a 1000% increase.

But let's do some pricing to place a PE value on the Company.

$1,000,000 a quarter in Profit is $4,000,000 (Million) a year.

18 Billion shares outstanding and 20 Billion Authorized. I will use the 20 Billion figure.

$4,000,000 divided by 20 Billion = $.0002 X PE =

PE 30 = $.006

PE 60 = $.012

PE 120 =$.024

High growth companies can sport a much higher PE.

Those numbers are for just $1,000,000 profit in a quarter.

How high will Profit be in Q2, Q3 and Q4.

So by the time this company is making profit of $5 million a quarter or $20 Million a year

and it will, the price per share will be at least PE 60 and at least $.06 per share.

Can it achieve that by Q2, Q3, or after Q4 earnings, I do believe so.

Could it do substantially more? Absolutely. Less, perhaps, but this is going to be huge.

Stock Rating: SUPER MONSTER

[JustGoDeep]

BIEL Currently Undergoing 400-500% Sales Growth Minimum

which will be reflected in Q2. 1000-2000% Price Gain by August 20th.

Biel: Current Market Cap $18 Million which is PUNY.

Biel is a billion dollar company in the making, having just gained traction in the last few months.

NHS IS HUGE, Government of the U.K. is going to pay for Actipatches.

READ:

FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting.
Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute

Average user uses 10.8 Actipatches per year, per the U.K. Study.

Keep in mind People Biel now has

Purdue's Mundi Pharmaceuticals on board in 9 Countries,

Teva's ANDA, INC. selling in America, and

Patterson Medical's Performance Health also selling in America.

Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.

Performance Health has 120 Boots on the Ground and 40 online sales people calling on

all the Physical Therapy Clinics in America, and most of the Long Term Facilities in America.

NHS decision data says saving of $582.00 per patient when they use Actipatch.

The Future for Biel has Never been brighter!!

https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf

NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.


https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html

Great Interview with their go to guy for sales and marketing.

https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/

Study NHS made their decision on. 10.8 Actipatches used a year per patient. Save $582 per patient AFTER

paying for 10.8 Actipatches.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf


------------------------

So much Great News will come out in

the next 6 months that I expect "at least" a 1000% increase.

But let's do some pricing to place a PE value on the Company.

$1,000,000 a quarter in Profit is $4,000,000 (Million) a year.

18 Billion shares outstanding and 20 Billion Authorized. I will use the 20 Billion figure.

$4,000,000 divided by 20 Billion = $.0002 X PE =

PE 30 = $.006

PE 60 = $.012

PE 120 =$.024

High growth companies can sport a much higher PE.

Those numbers are for just $1,000,000 profit in a quarter.

How high will Profit be in Q2, Q3 and Q4.

So by the time this company is making profit of $5 million a quarter or $20 Million a year

and it will, the price per share will be at least PE 60 and at least $.06 per share.

Can it achieve that by Q2, Q3, or after Q4 earnings, I do believe so.

Could it do substantially more? Absolutely. Less, perhaps, but this is going to be huge.

RATING: SUPER MONSTER!!

[JustGoDeep]

BIEL Currently Undergoing 400-500% Sales Growth Minimum

which will be reflected in Q2. 1000-2000% Price Gain by August 20th.

Biel: Current Market Cap $18 Million which is PUNY.

Biel is a billion dollar company in the making, having just gained traction in the last few months.

NHS IS HUGE, Government of the U.K. is going to pay for Actipatches.

FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting.
Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute

Average user uses 10.8 Actipatches per year, per the U.K. Study.

Keep in mind People Biel now has

Purdue's Mundi Pharmaceuticals on board in 9 Countries,

Teva's ANDA, INC. selling in America, and

Patterson Medical's Performance Health also selling in America.

Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.

Performance Health has 120 Boots on the Ground and 40 online sales people calling on

all the Physical Therapy Clinics in America, and most of the Long Term Facilities in America.

NHS decision data says saving of $582.00 per patient when they use Actipatch.

The Future for Biel has Never been brighter!!

https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf

NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.


https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html

Great Interview with their go to guy for sales and marketing.

https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/

Study NHS made their decision on. 10.8 Actipatches used a year per patient. Save $582 per patient AFTER

paying for 10.8 Actipatches.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf


------------------------

[JustGoDeep]

BIEL Currently Undergoing 400-500% Sales Growth Minimum

which will be reflected in Q2. 1000-2000% Price Gain by August 20th.

Biel: Current Market Cap $18 Million which is PUNY.

Biel is a billion dollar company in the making, having just gained traction in the last few months.

NHS IS HUGE, Government of the U.K. is going to pay for Actipatches.

FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting.
Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute

Keep in mind People Biel now has

Purdue's Mundi Pharmaceuticals on board in 9 Countries,

Teva's ANDA, INC. selling in America, and

Patterson Medical's Performance Health also selling in America.

Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.

Performance Health has 120 Boots on the Ground and 40 online sales people calling on

all the Physical Therapy Clinics in America, and most of the Long Term Facilities in America.

NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.


https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html

Great Interview with their go to Guy for Sales and Marketing.

https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/

Study NHS made their decision on. 10.8 Actipatches used a year per patient. Save $582 per patient AFTER

paying for 10.8 Actipatches.

http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf


------------------------